Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

354
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
354
Testosterone: Functions and Regulation01:26

Testosterone: Functions and Regulation

575
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
575
Menopause01:28

Menopause

145
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
145
Signs of Puberty01:27

Signs of Puberty

279
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
279
Infertility in Males01:23

Infertility in Males

255
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
255
Adrenal Gland Disorders01:27

Adrenal Gland Disorders

1.4K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adult Male Hypogonadism: A Review.

JAMA·2026
Same author

Primary Hyperparathyroidism in Adults: Recent Developments in Diagnosis and Management.

The Medical journal of Australia·2026
Same author

Development of Graves orbitopathy after thyroidectomy for thyroid cancer.

JCEM case reports·2026
Same author

Hypothalamic-Pituitary-Testicular Axis Regulation in Men With Type 2 Diabetes.

Clinical endocrinology·2026
Same author

Discordance Between Online Information and Male Hypogonadism Clinical Guidelines: A Global Multilingual Content Analysis.

The Journal of clinical endocrinology and metabolism·2026
Same author

EndoCompass Project: Endocrinology across the Lifespan.

Hormone research in paediatrics·2025
Same journal

EDITORIAL INTRODUCTION.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Exploring the role of parathyroid hormone in sarcopenia: A review.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Normocalcemic primary hyperparathyroidism: an update on diagnostic and management challenges.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Prediabetes before pregnancy: implications for risk stratification and research.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Secondary hyperparathyroidism in chronic kidney disease: update on pathophysiology and new treatment targets.

Current opinion in endocrinology, diabetes, and obesity·2026
Same journal

Revisiting the relationship between weight loss and bone health in people living with obesity: insights from the latest evidence.

Current opinion in endocrinology, diabetes, and obesity·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K

Indications for testosterone therapy in men.

Mathis Grossmann1,2

  • 1Department of Medicine (Austin Health), The University of Melbourne, Melbourne.

Current Opinion in Endocrinology, Diabetes, and Obesity
|September 23, 2024
PubMed
Summary
This summary is machine-generated.

Testosterone therapy benefits men with diagnosed hypogonadism. For older men with low testosterone and symptoms but no clear HPT axis disease, recent trials show short-term benefits, but long-term risks remain unknown.

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

686
Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
03:19

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Published on: August 30, 2024

690

Related Experiment Videos

Last Updated: Jun 12, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

686
Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation
03:19

Author Spotlight: Advancing Varicocele Treatment with Neuromuscular Electrical Stimulation

Published on: August 30, 2024

690

Area of Science:

  • Endocrinology
  • Men's Health
  • Andrology

Background:

  • Testosterone replacement therapy (TRT) is established for organic hypogonadism.
  • The use of TRT in older men with symptomatic androgen deficiency and low testosterone, but without clear hypothalamic-pituitary-testicular (HPT) axis disease, remains debated.
  • This condition is sometimes termed 'functional' or 'late-onset' hypogonadism.

Purpose of the Study:

  • To review recent data on the benefits and risks of testosterone therapy in middle-aged and older men with symptomatic androgen deficiency.
  • To evaluate the impact of TRT on various health parameters in this population.

Main Methods:

  • Review of three large randomized controlled clinical trials.
  • Analysis of data concerning sexual function, vitality, cognition, mood, glucose metabolism, physical function, hematologic parameters, bone, cardiovascular, and prostate health.

Main Results:

  • Recent trials provide new short-term to medium-term data on TRT in older men with hypogonadal symptoms.
  • Observed effects span sexual function, vitality, cognition, mood, metabolism, physical function, and hematologic, bone, cardiovascular, and prostate health.

Conclusions:

  • Findings support a more personalized approach to TRT for middle-aged and older men.
  • Long-term benefits and risks (beyond 3-4 years) of testosterone therapy in this group are still unknown.